• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以自动化赛沛Xpert Xpress SARS-CoV-2 PCR作为金标准,评估基于试剂盒的自动化ARIES SARS-CoV-2检测法(研究用)。

Evaluation of the automated cartridge-based ARIES SARS-CoV-2 Assay (RUO) against automated Cepheid Xpert Xpress SARS-CoV-2 PCR as gold standard.

作者信息

Tanida Konstantin, Koste Lars, Koenig Christian, Wenzel Werner, Fritsch Andreas, Frickmann Hagen

机构信息

1Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Hamburg, Hamburg, Germany.

2Department of Laboratory Medicine, Bundeswehr Hospital Hamburg, Hamburg, Germany.

出版信息

Eur J Microbiol Immunol (Bp). 2020 Aug 17;10(3):156-164. doi: 10.1556/1886.2020.00017.

DOI:10.1556/1886.2020.00017
PMID:32804668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7592518/
Abstract

INTRODUCTION

To evaluate the automated cartridge-based PCR approach ARIES SARS-CoV-2 Assay targeting the ORF-sequence and the N-gene of SARS-CoV-2.

METHODS

In line with the suggestions by Rabenau and colleagues, the automated ARIES SARS-CoV-2 Assay was challenged with strongly positive samples, weakly positive samples and negative samples. Further, intra-assay and inter-assay precision as well as the limit-of-detection (lod) were defined with quantified target RNA and DNA. The Cepheid Xpert Xpress SARS-Cov-2 Assay was used as gold standard.

RESULTS

Concordance between the ARIES assay and the Cepheid assay was 100% for strongly positive samples and for negative samples, respectively. For weakly positive samples as confirmed applying the Cepheid assay, a relevant minority of 4 out of 15 samples (26.7%) went undetected by the ARIES assay. Intra- and inter-assay precision were satisfactory, while the lod was in the 103 DNA copies/reaction-range, in the 103 virus copies/reaction-range, or in the 103-104 free RNA copies/reaction-range in our hands.

CONCLUSIONS

The automated ARIES assay shows comparable test characteristics as the Cepheid assay focusing on strongly positive and negative samples but a slightly reduced sensitivity with weakly positive samples. Decisions on diagnostic use should include considerations on the lod.

摘要

引言

评估基于试剂盒的自动化PCR方法——ARIES SARS-CoV-2检测法,该方法针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的开放阅读框序列和核衣壳蛋白基因(N基因)。

方法

按照拉贝瑙及其同事的建议,使用强阳性样本、弱阳性样本和阴性样本对自动化的ARIES SARS-CoV-2检测法进行测试。此外,使用定量的靶RNA和DNA来确定检测内和检测间的精密度以及检测限(lod)。以赛沛Xpert Xpress SARS-CoV-2检测法作为金标准。

结果

ARIES检测法与赛沛检测法之间,强阳性样本和阴性样本的一致性分别为100%。对于经赛沛检测法确认为弱阳性的样本,15个样本中有4个(26.7%)被ARIES检测法漏检。检测内和检测间的精密度令人满意,而在我们的实验中,检测限处于10³个DNA拷贝/反应范围、10³个病毒拷贝/反应范围或10³-10⁴个游离RNA拷贝/反应范围内。

结论

自动化的ARIES检测法在针对强阳性和阴性样本时,显示出与赛沛检测法相当的检测特性,但对弱阳性样本的敏感性略有降低。关于诊断用途的决策应考虑检测限。

相似文献

1
Evaluation of the automated cartridge-based ARIES SARS-CoV-2 Assay (RUO) against automated Cepheid Xpert Xpress SARS-CoV-2 PCR as gold standard.以自动化赛沛Xpert Xpress SARS-CoV-2 PCR作为金标准,评估基于试剂盒的自动化ARIES SARS-CoV-2检测法(研究用)。
Eur J Microbiol Immunol (Bp). 2020 Aug 17;10(3):156-164. doi: 10.1556/1886.2020.00017.
2
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.SARS-CoV-2 大流行期间赛沛 Xpert® Xpress SARS-CoV-2 即时检测的多中心评估。
J Clin Virol. 2020 Jul;128:104426. doi: 10.1016/j.jcv.2020.104426. Epub 2020 May 11.
3
Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2.BioFire COVID-19 测试、BioFire 呼吸道Panel 2.1 与 Cepheid Xpert Xpress SARS-CoV-2 检测试剂盒对 SARS-CoV-2 样本至报告结果检测的临床评估
Genes (Basel). 2023 Jan 16;14(1):233. doi: 10.3390/genes14010233.
4
Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay.使用 Cepheid Xpert® Xpress SARS-CoV-2 检测对 Cepheid GeneXpert® 系统进行样本混合的建议。
PLoS One. 2020 Nov 9;15(11):e0241959. doi: 10.1371/journal.pone.0241959. eCollection 2020.
5
Validation of the Cepheid Xpert® Xpress SARS-CoV-2 using upper and lower respiratory tract specimens.使用上呼吸道和下呼吸道标本对赛沛Xpert® Xpress新型冠状病毒2进行验证。
Eur J Microbiol Immunol (Bp). 2022 Mar 14;12(1):18-21. doi: 10.1556/1886.2022.00003.
6
Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.采用赛沛 Xpert Xpress SARS-CoV-2/Flu/RSV 检测,可将气管抽吸物和支气管肺泡灌洗液作为新冠病毒检测的潜在标本类型。
Microbiol Spectr. 2022 Jun 29;10(3):e0039922. doi: 10.1128/spectrum.00399-22. Epub 2022 May 18.
7
Comparative Evaluation of a Standard M10 Assay with Xpert Xpress for the Rapid Molecular Diagnosis of SARS-CoV-2, Influenza A/B Virus, and Respiratory Syncytial Virus.采用Xpert Xpress对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)、甲型/乙型流感病毒及呼吸道合胞病毒进行快速分子诊断的标准M10检测方法的比较评估
Diagnostics (Basel). 2023 Nov 22;13(23):3507. doi: 10.3390/diagnostics13233507.
8
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.多中心评估赛沛 Xpert Xpress SARS-CoV-2/Flu/RSV 检测。
J Clin Microbiol. 2021 Feb 18;59(3). doi: 10.1128/JCM.02955-20.
9
Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant.经 Cepheid Xpert Xpress SARS-CoV-2 检测,由于德尔塔变异株中 N 突变,结果为疑似阳性。
Diagn Microbiol Infect Dis. 2022 Jul;103(3):115699. doi: 10.1016/j.diagmicrobio.2022.115699. Epub 2022 Apr 21.
10
Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage.用于支气管肺泡灌洗的赛沛Xpert Xpress新型冠状病毒2019检测的评估。
J Clin Virol Plus. 2022 Jun;2(2):100067. doi: 10.1016/j.jcvp.2022.100067. Epub 2022 Feb 19.

引用本文的文献

1
Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States.美国主要商业严重急性呼吸综合征冠状病毒 2 分子检测的分析和临床性能。
Clin Lab Med. 2022 Jun;42(2):129-145. doi: 10.1016/j.cll.2022.02.001. Epub 2022 Feb 21.
2
FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances.美国食品药品监督管理局批准的分子即时检测严重急性呼吸综合征冠状病毒2检测:对原理、系统和临床性能的批判性综述。
Biosens Bioelectron X. 2022 Sep;11:100158. doi: 10.1016/j.biosx.2022.100158. Epub 2022 May 21.
3
Diagnosing SARS-CoV-2 with Antigen Testing, Transcription-Mediated Amplification and Real-Time PCR.通过抗原检测、转录介导扩增和实时聚合酶链反应诊断严重急性呼吸综合征冠状病毒2
J Clin Med. 2021 May 29;10(11):2404. doi: 10.3390/jcm10112404.
4
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.用于严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)/COVID-19 检测的工具和技术。
Clin Microbiol Rev. 2021 May 12;34(3). doi: 10.1128/CMR.00228-20. Print 2021 Jun 16.
5
SARS-CoV-2 E Gene Variant Alters Analytical Sensitivity Characteristics of Viral Detection Using a Commercial Reverse Transcription-PCR Assay.严重急性呼吸综合征冠状病毒2型E基因变异改变了使用商业逆转录聚合酶链反应检测方法进行病毒检测的分析灵敏度特征。
J Clin Microbiol. 2021 Jun 18;59(7):e0007521. doi: 10.1128/JCM.00075-21.
6
COVID-19 Pandemic: Review of Contemporary and Forthcoming Detection Tools.COVID-19大流行:当代及未来检测工具综述
Infect Drug Resist. 2021 Mar 17;14:1049-1082. doi: 10.2147/IDR.S289629. eCollection 2021.
7
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原和基于分子的检测。
Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2.
8
Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies.用于检测新型冠状病毒 2 型抗体的五种血清学检测方法的比较
Diagnostics (Basel). 2021 Jan 6;11(1):78. doi: 10.3390/diagnostics11010078.

本文引用的文献

1
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel.美国疾病控制与预防中心2019新型冠状病毒(2019-nCoV)实时逆转录聚合酶链反应诊断试剂首批产品分析。
PLoS One. 2021 Dec 15;16(12):e0260487. doi: 10.1371/journal.pone.0260487. eCollection 2021.
2
Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.新型冠状病毒肺炎成年住院患者痰液与鼻咽拭子标本中 2019 年冠状病毒脱落持续时间的差异。
Chest. 2020 Nov;158(5):1876-1884. doi: 10.1016/j.chest.2020.06.015. Epub 2020 Jun 20.
3
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.雅培 ID Now COVID-19 快速核酸扩增检测试剂使用鼻咽拭子和干鼻拭子在纽约市学术机构中运输的病毒运输介质的性能。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
4
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.I 型和 III 型干扰素 - 诱导、信号转导、逃逸及其在抗击 COVID-19 中的应用。
Cell Host Microbe. 2020 Jun 10;27(6):870-878. doi: 10.1016/j.chom.2020.05.008. Epub 2020 May 27.
5
Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.罗氏Cobas 6800与赛沛GeneXpert Xpress SARS-CoV-2检测在高循环阈值范围内的检测一致性
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01187-20.
6
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.Cepheid Xpert Xpress 和 Abbott ID Now 与 Roche cobas 用于 SARS-CoV-2 快速检测的比较。
J Clin Virol. 2020 Jul;128:104428. doi: 10.1016/j.jcv.2020.104428. Epub 2020 May 13.
7
Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study.与中国武汉以外地区成人 COVID-19 病毒脱落持续时间相关的因素:一项回顾性队列研究。
Int J Infect Dis. 2020 Jul;96:531-537. doi: 10.1016/j.ijid.2020.05.045. Epub 2020 May 17.
8
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.SARS-CoV-2 大流行期间赛沛 Xpert® Xpress SARS-CoV-2 即时检测的多中心评估。
J Clin Virol. 2020 Jul;128:104426. doi: 10.1016/j.jcv.2020.104426. Epub 2020 May 11.
9
Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays.使用三种商业分子检测试剂盒检测鼻咽拭子中低水平的 SARS-CoV-2 RNA。
J Clin Virol. 2020 Jul;128:104387. doi: 10.1016/j.jcv.2020.104387. Epub 2020 Apr 28.
10
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.赛沛Xpert Xpress SARS-CoV-2检测的多中心评估
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00926-20.